Zeria Pharmaceutical Co., Ltd. (4559.T) JPX

Currency In JPY

AD

Valuation

Market Cap96.75B
Enterprise Value108.1B
P/E Ratio10.17
PEG Ratio0.49
Price/Sales Ratio0.92
Price/Book Ratio0.77
Enterprise/Revenue1.01
Enterprise/EBITDA4.47

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.09
Operating Margin0.14
AD

Management Effectiveness

Return On Assets0.05
Return On Equity0.08

Income Statement

Revenue89.16B
Revenue/Share2,067.13
Gross Profit65.18B
EBITDA19.72B
Net Income8.45B
Diluted EPS191.8

Balance Sheet

Total Cash27.71B
Total Cash/Share628.55
Total Debt36.47B
Total Debt/Equity0.34
Current Ratio1.55
Book Value Per Share2,456.3

Price History

52-Week Change-5.15
52-Week High2,434
52-Week Low1,878
Moving Average 50 Days2,044.5
Moving Average 200 Days2,130.85

Statistics

Average Volume133,225
Shares Outstanding44.08M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate50
Trailing Annual Dividend Yield2.63
Payout Ratio0
Last Split Factor11:10
Last Split DateSeptember 26, 2013
AD